Abstract:Objective To evaluate a strategy of using TF siRNA loaded in a novel external stent prepared by hybrid uhrafine fibrous membrane consisting of PLGA/Chitosan nannoparticles as a therapy for vein graft disease.Methods Hybrid ultrafine fibrous membranes consisting of PLGA/Chitosan nannoparticles were fabricated via a specially designed electrospinning setup. After soaking in chloroform to dissolve PLGA. the amount of chitosan in the hybrid membranes was determined. The water uptake of the hybrid ultrafine fibrous membranes was investigated by incubation in phosphate buffer solution.Right jugular vein-carotid artery interposition grafting models in Spragne-Dawley rats were randomly divided into five groups:Group A(external stent consisting of PLGA/CS-TFsiRNA nanoparticles),Group B(external stent consisting of PLGA/CS.Stealth~(TM) RNAi negative control nanoparticles),Group C(external stent consisting of PLGA/CS blank nanoparticles),Group D(external stent consisting of PLGA),Group E(without perivenous extereal stent).BLOCK-iT~(TM) Fluorescent Oligo was used to confirm its stability and successful transfer into the vein graft wall.The vein grafts were harvested at 1,3,7,14,28 d after operation,respectively.The TF protein expression of vein grafts was analyzed by Westem blot and immunochemistry at 1,3,7 d after operation,respectively.The expression of proliferating cell nuclear antigen(PCNA)was identified by immunochemistry methods. The thickness of neointima at 28 d was calculatod by computer imaging analysis system. Results The PLGA and CS amount in PLGA/Chitosan nannoparticles membranes could be well controlled by adjusting the flow rate for electrospinning of PLGA and chitosan nannoparticles, respectively. Because of the introduction of chitosan,which is a naturally hydrophilic polymer,the hybrid membranes exhibited good water absorption properties.BIOCK-iT~(TM) Fluorescent Oligo could be detected in the graft wall even 12days after operation.The expression of TF protein in Group A Was significantly less than that in control groups at 3 d after operation(P＜0.05,0.40±0.03 vs 0.75 ±0.01、0.75 ±0.05、0.77 ±0.07)and at 7 d after operation(P＜0.05,0.30±0.03 vs 0.84±0.05、0.86±0.06、0.85±0.06).The expression of PCNA in Group A decreased significantly in comparison with control groups at 14 d after operation(P＜0.01,13.0%±2.6%vs 25.0%±2.8%、24.2%±3.9%、24.0%±4.1%、44.8%±3.7%).The thickness of neointima at 28 d after grafting in Group A Was significantly less than the untreated group(P＜0.01,18.8μm±2.9 μm vs 38.7 μm±5.0μm、37.3μm ±3.6 μm、37.2μm±2.6μm、67.5μm±4.8μm).Conclusion rrhe hovel external stent prepared by hybrid uhrafine fibrous membrane consisting of PLGA/Chitosan nannoparticles inhibits early neointima formation in rat vein grafts.This strategy may be a practicable and promising form of gene delivery against vein graft failure.

A Novel External Stent Prepared by Electospinning Reduces Neointimal Hyperplasia of Vein Grafts

Effects of the Different-Sized External Stents on Vein Graft Intimal Hyperplasia and Inflammation

Controlled release of siRNA nanoparticles loaded in a novel external stent prepared by emulsion electrospinning attenuates neointima hyperplasia in vein grafts

A Soft, Conductive External Stent Inhibits Intimal Hyperplasia in Vein Grafts by Electroporation and Mechanical Restriction

Can Endothelial Seeding Enhance Patency and Inhibit Neointimal Hyperplasia? Experimental Studies and Clinical Trial of Endothelial Seeded Venous Prostheses

Bletilla striata Polysaccharide Prevents Restenosis of Vein Graft Through Inhibiting Cell Proliferation in Rat Model

A novel biodegradable external stent regulates vein graft remodeling via the Hippo-YAP and mTOR signaling pathways

Experimental Study of 103pd Stents for Preventing the Restenosis of Biliary Duct

3d Elastomeric Stent Functionalized with Antioxidative And Perivascular Tissue Regenerative Activities Ameliorated Pvt Deprivation‐Induced Vein Graft Failure

Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation

Effects of SDF-1α on vein graft restenosis in rats

Platelet Membrane-Encapsulated Poly(lactic- co-glycolic acid) Nanoparticles Loaded with Sildenafil for Targeted Therapy of Vein Graft Intimal Hyperplasia

Effects of distension on postoperative restenosis of rabbit external jugular vein graft

Administration of a new nano delivery system coated with Tirofiban to prevent early thrombosis of vein graft

Fabrication of small-diameter in situ tissue engineered vascular grafts with core/shell fibrous structure and a one-year evaluation via rat abdominal vessel replacement model

The Effect of the Fibrin Glue Perivenous Support on the Prolifelation and Apoptosis of the Vascular Smooth Muscle Cells

The Placental Growth Factor Attenuates Intimal Hyperplasia in Vein Grafts by Improving Endothelial Dysfunction.

Heparin and Vascular Endothelial Growth Factor Loaded Poly(L-lactide-co-caprolactone) Nanofiber Covered Stent-Graft for Aneurysm Treatment

An experimental study of a new stent graft

Periadventitial human stem cell treatment reduces vein graft intimal thickening in pig vein-into-artery interposition grafts

Thrombosis And Neointima Formation In Vein Grafts Are Inhibited By Locally Applied Aspirin Through Endothelial Protection